Academic Jobs - Home of Higher Ed Logo

MAV Dizziness: Symptoms, Causes, and Treatment Options

Post a Story
624views
Native advertising — guest articles from $400See packages
a man holding his hands to his ears
Photo by Vitaly Gariev on Unsplash

MAV dizziness rarely announces itself with the drama most expect. A patient may feel the room tilt during a routine commute or sense the floor shift while reading a screen. The sensation passes or lingers, yet standard ear tests return normal. What registers instead is a pattern tied to migraine biology rather than isolated vestibular failure.

Physicians now recognize this presentation as vestibular migraine, also called migraine-associated vertigo or MAV. It ranks as the second most common cause of recurrent vertigo in adults. Prevalence estimates place it between one and three percent of the general population, with higher rates among those already diagnosed with migraine.

The range of sensations patients report

Symptoms vary more than the term “dizziness” suggests. Some describe true spinning vertigo that lasts minutes to three days. Others note a persistent sense of motion, unsteadiness on level ground, or intolerance to head movement and visual motion. Nausea often accompanies these episodes, along with sensitivity to light or sound even when head pain stays absent.

Many experience brain fog, word-finding trouble, neck discomfort, or a floating detachment from surroundings. These features appear in clusters rather than isolation. At least half the attacks must include one migraine marker for the diagnosis to hold under current criteria.

Episodes can strike without warning or follow identifiable triggers such as skipped meals, disrupted sleep, stress spikes, or certain foods. The absence of headache in a majority of attacks explains why the condition slips past initial screening in both headache and dizziness clinics.

Man holding head in frustration at desk with laptop.

Photo by Vitaly Gariev on Unsplash

Diagnostic criteria that bring clarity

Consensus standards from the Bárány Society and International Headache Society require five or more episodes of moderate to severe vestibular symptoms lasting five minutes to seventy-two hours. A current or prior migraine history must exist. At least half those episodes need one accompanying migraine feature: characteristic headache, photophobia plus phonophobia, or visual aura. Other explanations must be ruled out first.

The process demands careful history taking. Imaging and basic vestibular tests often prove unremarkable, which itself narrows the field. Patients frequently consult multiple specialists before the link surfaces. One recent review noted diagnosis rates as low as ten to twenty percent in referred populations despite the condition’s frequency.

Why the vestibular system becomes involved

The precise mechanisms remain under study, yet the disorder reflects altered sensory processing within the central nervous system rather than primary inner-ear damage. Migraine pathways appear to lower the threshold for vestibular signals, producing symptoms even when peripheral structures function normally. Genetic predisposition combines with environmental factors such as hormonal shifts or metabolic stress.

Women experience the condition three to four times more often than men. Onset commonly occurs in the thirties or forties, though cases appear across age groups, including children where it may manifest as benign paroxysmal vertigo. Comorbid anxiety or motion sensitivity can amplify the picture without constituting the root cause.

Man in suit sitting on couch with head in hands.

Photo by Vitaly Gariev on Unsplash

Management that addresses the full picture

No single medication carries a vestibular-migraine-specific label. Treatment mirrors broader migraine strategies and works best when layered. Acute attacks may respond to triptans for headache components, anti-nausea agents, or short courses of vestibular suppressants used sparingly to avoid dependence. Newer gepants offer additional options for some patients.

Preventive approaches include beta-blockers, certain antidepressants, anticonvulsants such as topiramate, and calcium-channel blockers. Emerging CGRP-targeted therapies show promise in reducing attack frequency. Supplements like magnesium, riboflavin, or coenzyme Q10 receive mention in clinical discussions, though evidence varies.

Lifestyle measures form the foundation. Consistent sleep schedules, regular meals, hydration, stress reduction, and trigger tracking reduce episode burden for many. A patient who identifies that red wine or irregular fasting precedes attacks gains immediate leverage.

Vestibular rehabilitation therapy adds targeted benefit when imbalance or motion hypersensitivity persists between attacks. Exercises retrain the brain’s integration of visual, proprioceptive, and vestibular input. Progress often appears gradually, with some individuals achieving remission after years of symptoms once the right combination stabilizes.

Vestibular disorders resources from the Vestibular Disorders Association outline these multimodal elements in detail. Similar guidance appears on specialized migraine sites that emphasize individualized plans over one-size protocols.

Living with the condition over time

Many patients describe an initial period of repeated emergency visits before patterns emerge. Once identified, the focus shifts from crisis response to prevention. One individual reported severe bouts requiring hospitalization that later reduced to infrequent episodes managed with medication kept on hand and prompt lifestyle corrections.

Work and daily function can suffer during active phases, yet remission remains attainable. Recent discussions among clinicians highlight cases of people dizzy for decades who regain stability through consistent management rather than any single intervention. The condition does not progress to permanent vestibular loss in most instances.

Continued research explores central sensitization pathways and potential biomarkers, yet current care already delivers meaningful relief when applied early and comprehensively. The barrier remains recognition more than available tools.

Portrait of Prof. Clara Voss
About the author

Prof. Clara VossView author

Academic Jobs In House Author

Discussion

Sort by:

Be the first to comment on this article!

You

You’ll be asked to sign in before your comment is posted.

New0 comments

Join the conversation!

Add your comments now!

Have your say

Engagement level

Browse by Faculty

Browse by Subject

Frequently Asked Questions

🌀What exactly is MAV dizziness?

MAV stands for migraine-associated vertigo, also termed vestibular migraine. It produces recurrent episodes of dizziness or vertigo linked to migraine biology even when head pain is absent.

⏱️How long do MAV episodes typically last?

Attacks range from five minutes to seventy-two hours. Moderate to severe intensity distinguishes them from fleeting lightheadedness.

💡Does MAV always involve headache?

No. Many patients experience dizziness as the dominant or sole symptom. Migraine features such as light or sound sensitivity still appear in at least half the episodes.

📋What triggers MAV dizziness most often?

Common triggers include irregular sleep, skipped meals, stress, hormonal changes, and specific dietary items. Tracking personal patterns helps reduce frequency.

🔍How is vestibular migraine diagnosed?

Clinicians apply Bárány Society criteria: five or more qualifying episodes, migraine history, and migraine features during attacks, after excluding other causes.

💊Are medications the only treatment?

No. Effective plans combine acute and preventive medications with lifestyle adjustments and, when needed, vestibular rehabilitation therapy.

🏃Can vestibular rehabilitation help MAV?

Yes. Targeted exercises improve balance and reduce motion sensitivity between attacks for many patients, especially those with lingering unsteadiness.

👩Is MAV more common in women?

Yes. Women experience it three to four times more often than men, consistent with broader migraine patterns.

📈How long before symptoms improve with treatment?

Response varies. Some notice fewer attacks within weeks of lifestyle changes and medication; others require months of consistent multimodal management to reach remission.

✅Can MAV lead to permanent balance loss?

Most cases do not progress to permanent vestibular damage. Many patients achieve substantial or complete control with proper management.

🩺When should someone seek specialist care?

Recurrent unexplained dizziness warrants evaluation by a neurologist or neurotologist familiar with vestibular migraine criteria.